Pattern hair loss can begin long before the change becomes obvious in the mirror.
At Dermatology Circle, clinical examination, standardized photography and digital trichoscopy help identify follicular miniaturization and establish a measurable baseline.
Treatment is selected around the diagnosis, stage of hair loss, medical history and long-term goals rather than around a predetermined procedure.
Androgenetic alopecia affects both women and men, but its distribution, progression and visual presentation can differ considerably.
Women commonly notice increasing visibility of the scalp through the central part or crown. The frontal hairline may remain relatively preserved.
Men may develop frontal or temporal recession, thinning at the vertex, or a combination of several androgen-sensitive patterns.
Common presentations include a widening part, reduced central scalp density and gradually increasing scalp visibility.
Male pattern loss may affect the hairline, temporal areas and crown in different combinations.
Susceptible follicles gradually begin producing finer and shorter hairs.
This process is known as follicular miniaturization. Genetics and androgen signaling play important roles, but the biology — particularly in women — is more complex than a single hormone level.
Thicker shaft and a longer growth cycle.
Increasing variation in shaft diameter.
Progressively finer and shorter hairs.
Magnified scalp imaging can reveal follicular changes before they become obvious from a normal viewing distance.
Digital images can also be stored and compared during future visits, creating a more objective record of progression and response.
Miniaturized hairs and variation in shaft caliber can support the clinical diagnosis.
A mixture of thicker terminal hairs and finer miniaturized hairs is characteristic of pattern loss.
Pattern hair loss can coexist with temporary shedding, inflammatory scalp disease or another form of alopecia.
A detailed hair loss consultation may include history, scalp examination, standardized photography and digital trichoscopy.
Laboratory testing is individualized. A scalp biopsy may be useful when findings are atypical or an inflammatory or scarring process is suspected.
Hair restoration develops gradually. Standardized photography helps document change more reliably than memory alone.
Individual results vary.
Pattern hair loss treatment is usually a long-term strategy rather than a single intervention.
Establishing a baseline early allows future photography and trichoscopy to be compared against a meaningful starting point.
View an Early Hair Thinning CasePattern hair loss is chronic, but progression is not always visually obvious.
Treatment can often slow or stabilize progression and may produce meaningful improvement, particularly while follicles remain active and miniaturizing.
The diagnosis may be shared, but medication selection, risk assessment and treatment priorities are not necessarily the same.
Treatment selection may depend on age, severity, hormonal history, medical conditions and reproductive plans.
Treatment may focus on maintaining existing density, limiting progression and supporting miniaturized follicles.
Pattern hair loss management should be a strategy, not a collection of procedures.
Medical therapy often forms the foundation. Additional approaches are selected according to diagnosis, severity, tolerance and patient goals.
Prescription decisions require individualized consideration of medical history, sex, reproductive context, expected benefit and potential risk.
A foundational treatment option for many women and men with androgenetic alopecia.
Established OptionFDA-approved for male pattern hair loss. Benefits, adverse effects and individual risks should be reviewed.
Men · FDA-ApprovedLow-dose oral minoxidil may be considered off-label after individualized risk assessment.
Off-LabelMay be considered in selected women depending on presentation, medical history and reproductive context.
Selected WomenIn the United States, dutasteride use for androgenetic alopecia is off-label.
Off-Label for AGAProcedural options are considered within the broader treatment strategy rather than automatically added to every plan.
PRP may provide additional support for selected patients with nonscarring pattern hair loss.
Explore PRP 02May be considered as part of an individualized off-label strategy for selected patients.
Explore MesotherapyMay be considered as an adjunct within selected hair-loss protocols.
Adjunctive OptionCertain low-level light devices may provide additional support for pattern hair loss.
Explore LLLTHair transplantation can redistribute follicles, but it does not stop progression of androgenetic alopecia in untreated native hair.
For many patients — particularly younger patients — long-term preservation should be considered alongside surgical planning.
Early follow-up is often about treatment tolerance and stability, while meaningful visual reassessment requires more time.
Photography and trichoscopy establish the starting point.
Review tolerance, adherence and early clinical changes.
Standardized imaging becomes increasingly useful for comparison.
Pattern hair loss generally requires ongoing management.
The goal is not to perform as many hair-restoration procedures as possible.
The goal is to establish the diagnosis, select treatments with a clear role and document whether the strategy is actually working.
Hair-loss treatment starts with understanding the diagnosis — clinically and, when needed, microscopically.
Dr. Kazlouskaya is board-certified in dermatology and dermatopathology. This background can be particularly useful when pattern hair loss overlaps with inflammatory scalp disease or when the diagnosis is not straightforward.
Digital trichoscopy, clinical examination and longitudinal documentation are used to guide treatment over time.
Detailed diagnostic visits, digital trichoscopy and individualized long-term treatment in a private, physician-led practice.
Treatment decisions become clearer once the diagnosis and baseline are established.
Yes. Pattern hair loss is chronic, but treatment can often slow or stabilize progression and may produce meaningful improvement, particularly while follicles remain active and miniaturizing.
There is no single best treatment for every woman. Minoxidil, selected antiandrogen strategies and adjunctive treatments may be considered depending on age, severity, medical history and reproductive plans.
Not necessarily. Many women with female pattern hair loss do not have elevated circulating androgens. Genetics, follicular sensitivity and other biological factors may contribute.
Stress does not usually create androgenetic alopecia, but physiological or psychological stress may trigger telogen effluvium and temporarily increase shedding.
Telogen effluvium commonly causes increased diffuse shedding after a trigger. Androgenetic alopecia involves progressive follicular miniaturization. Both conditions can occur together.
Yes. Family history is common, but its absence does not exclude androgenetic alopecia.
Selected patients may consider adjunctive approaches such as PRP, low-level light therapy or procedural treatments. Their role and evidence vary, and they do not automatically replace appropriate medical treatment.
Benefits from many pattern-hair-loss treatments depend on continued use. After treatment is discontinued, some treatment-related gains may gradually be lost.
Not every patient needs the same laboratory testing. Blood work may be useful when history, symptoms or examination suggest another contributor to hair loss.
Straightforward androgenetic alopecia can often be diagnosed clinically and with trichoscopy. Biopsy may be considered when findings are atypical or an inflammatory or scarring disorder is suspected.
No. Hair transplantation redistributes donor follicles but does not stop progression of androgenetic alopecia in untreated native hair.
Begin with a diagnosis, measurable baseline and an individualized long-term strategy.
Private Hair Loss Consultation Schedule Your Evaluation